Pharmafile Logo
Pharmafocus logo
Advanced Search

Gleevec

Showing 9 posts of 9 posts found.

novartis_outside_1

Novartis rides out fiscal hardship to beat Q3 forecasts

October 25, 2016
Manufacturing and Production, Sales and Marketing Entresto, Gleevec, Novartis

Novartis has beaten its third-quarter sales projections, announcing that new product growth and cost cuts managed to carry the company …

News
sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …

News
Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

News
Novartis image

Novartis sales below forecast in ‘transformative’ year

January 28, 2015
Sales and Marketing Diovan, Exforge, Gleevec, Jimenez, Novartis, amlodipine, q4, valsartan

Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …

News
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News

Sales rise for Novartis

January 30, 2014
Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

News
Glivec

Glivec cleared for longer use in GIST patients

February 28, 2012
Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis

Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …

News

Trial hitch for Pfizer’s leukaemia drug submission plans

December 7, 2010
Research and Development, Sales and Marketing CML, Gleevec, Glivec, Pfizer, bosutinib, chronic myeloid leukaemia

Pfizer is pressing ahead with plans to submit bosutinib for European approval despite the chronic myeloid leukaemia drug missing its …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026